The results suggested that depletion of CD8+ T cells weakened the inhibitory effect of Dtx2 knockdown on tumor growth, while depletion of CD4+ T cells had no such effect (Figure S3H–J, Supporting Information). The gene discussed is CD4; the disease is neoplasm.